AVITA Medical

Historical price data

AVITA Medical is a mission-driven company focused on transforming lives through innovative therapeutic acute wound care solutions. Its core achievement is the FDA-approved RECELL® System, a disruptive autologous cell harvesting technology that has established a global commercial footprint in burn care. The company's strategy is to leverage the RECELL platform for label expansion into traumatic and surgical wounds while building a comprehensive acute wound care portfolio through complementary products like PermeaDerm® and Cohealyx™. This approach aims to drive growth by addressing significant unmet needs across the continuum of acute wound management.

The RECELL® System is an autologous cell harvesting platform that uses a small patient skin sample to prepare a suspension of Spray-On Skin™ Cells at the point of care, enabling rapid re-epithelialization for acute wounds.